From https://projects.propublica.org/docdollars. © Copyright 2013 Pro Publica Inc.
AbbVie
Based in suburban Chicago, AbbVie was created in January 2013 when Abbott Laboratories spun off its pharmaceuticals business. In May 2012, Abbott pleaded guilty and agreed to pay $1.5 billion to settle accusations about its promotion of the drug Depakote for uses not approved by the Food and Drug Administration.
AbbVie began reporting payments for speaking, serving on a data monitoring board, research, meals, travel and educational items as of July 2012. AbbVie combines all categories into a single amount.
AbbVie's 2013 U.S. sales: $12.1 billion. Source: IMS Health.
See all AbbVie payments, or visit AbbVie's transparency page.
Notable drugs
- Humira (rheumatoid arthritis, ankylosing spondylitis, juvenile arthritis, ulcerative colitis, Crohn's disease, plaque psoriasis)
- Trilipix/Tricor (high cholesterol and high triglyceride levels)
- Niaspan (cholesterol, high triglyceride levels , atherosclerotic disease)
- AndroGel (testosterone replacement therapy, hypogonadism)
- Lupron (endometriosis, fibroids, advanced prostate cancer, central precocious puberty)
- Synthroid (hypothyroidism, pituitary TSH suppression)
- Kaletra (HIV)
- Creon (exocrine pancreatic insufficiency due to cystic fibrosis, chronic pancreatitis, pancreatectomy, or other conditions.)
- Norvir (HIV)
- Zemplar (overactive parathyroid glands associated with chronic kidney disease)
Payment Reports
2012 July to Dec.
Avg. Quarterly | Total | |
---|---|---|
Combination | $8,984,659 | $17,969,317 |
$8,984,659 | $17,969,317 |
2013 Jan. to Dec.
Avg. Quarterly | Total | |
---|---|---|
Combination | $8,786,474 | $35,145,897 |
$8,786,474 | $35,145,897 |
2013 Jan. to Dec. Research
Avg. Quarterly | Total | |
---|---|---|
Research | $2,382,192 | $9,528,767 |
$2,382,192 | $9,528,767 |
Total Payments by State
State | Total |
---|---|
California | $8,496,273 |
New York | $6,317,300 |
Texas | $5,736,941 |
Florida | $4,697,244 |
Pennsylvania | $3,271,649 |
Illinois | $2,774,154 |
New Jersey | $3,070,758 |
North Carolina | $2,035,321 |
Ohio | $1,939,603 |
Georgia | $1,805,345 |
Maryland | $1,777,034 |
Massachusetts | $1,382,604 |
Michigan | $1,254,124 |
Tennessee | $1,222,253 |
Missouri | $1,183,127 |
Colorado | $1,165,030 |
Kentucky | $1,159,552 |
Washington | $1,060,609 |
Connecticut | $1,028,947 |
Virginia | $1,018,345 |
Arizona | $970,118 |
Indiana | $908,390 |
Alabama | $824,903 |
Puerto Rico | $749,440 |
Louisiana | $729,447 |
South Carolina | $719,211 |
Wisconsin | $635,394 |
Utah | $545,910 |
Nevada | $491,493 |
Oklahoma | $409,301 |
Rhode Island | $352,030 |
District of Columbia | $343,203 |
Kansas | $290,733 |
Idaho | $288,574 |
Oregon | $262,474 |
West Virginia | $230,442 |
Mississippi | $214,304 |
Nebraska | $210,228 |
New Hampshire | $163,680 |
Arkansas | $144,146 |
Hawaii | $142,582 |
Delaware | $138,290 |
Minnesota | $128,786 |
Iowa | $110,342 |
Maine | $106,292 |
New Mexico | $82,724 |
South Dakota | $15,532 |
Alaska | $15,492 |
Montana | $6,860 |
North Dakota | $6,495 |
Wyoming | $6,063 |
Vermont | $4,456 |
[Unknown State] | $330 |
What Companies Disclose
See which services pharmaceutical companies report paying health practitioners for.
Big Pharma’s Big Fines
Drug companies have paid billions to the Department of Justice to resolve allegations of health care fraud. See some of the biggest settlements.